Association of Modified Systemic Lupus Erythematosus Responder Index Attainment and Long-Term Clinical Outcomes: A Five-Year Prospective Study.
Kathryn ConnellyRangi Kandane-RathnayakeAlberta Y HoiWorawit LouthrenooLaniyati HamijoyoShue Fen LuoYeong-Jian Jan WuJiacai ChoAisha LateefC S LauYi-Hsing ChenSandra NavarraLeonid ZamoraZhanguo LiYuan AnSargunan SockalingamYanjie HaoZhuoli ZhangMadelynn ChanYasuhiro KatsumataMasayoshi HarigaiShereen OonSang-Cheol BaeSean O'NeillKathryn A GibsonBmdb BasnayakeJun KikuchiTsutomu TakeuchiKristine Pek Ling NgNicola TugnetSunil KumarFiona GoldblattAnnie LawMichael TeeCherica TeeYoshiya TanakaNaoaki OhkuboJin Yu TanChetan S KaryekarMandana NikpourVera GolderEric F MorandPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2022)
In SLE patients with active disease receiving standard of care, mSRI attainment predicts favourable outcomes over long-term follow up, supporting the clinical meaningfulness of SRI as an SLE trial endpoint. This article is protected by copyright. All rights reserved.